Ligand Pharmaceuticals Inc. (LGND) at a glance

Ligand Pharmaceuticals Inc. (LGND) is a mid-cap Healthcare company. It trades at $284.47, with a P/E of 33.3, a 55.9% profit margin and revenue growth of 14.1%. It does not pay a dividend. Vestovix scores it 52/100 overall. Its strongest dimension is Momentum (68/100) and its weakest is Income (40/100). Its volatility is roughly in line with the market.

Price

$284.47

Market cap

$5.12B

P/E ratio

33.3

Dividend yield

None

Beta

1.04

52-week range

$158.40 to $326.63